SK23898A3 - Zwitterionic forms of trovafloxacin - Google Patents

Zwitterionic forms of trovafloxacin Download PDF

Info

Publication number
SK23898A3
SK23898A3 SK238-98A SK23898A SK23898A3 SK 23898 A3 SK23898 A3 SK 23898A3 SK 23898 A SK23898 A SK 23898A SK 23898 A3 SK23898 A3 SK 23898A3
Authority
SK
Slovakia
Prior art keywords
trovafloxacin
hygroscopic
crystalline form
zwitterionic
polymorphic
Prior art date
Application number
SK238-98A
Other languages
English (en)
Slovak (sk)
Inventor
Douglas J M Allen
David B Joseph
Timothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SK23898A3 publication Critical patent/SK23898A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)
SK238-98A 1995-08-29 1996-07-29 Zwitterionic forms of trovafloxacin SK23898A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29
PCT/IB1996/000756 WO1997007800A1 (en) 1995-08-29 1996-07-29 Zwitterionic forms of trovafloxacin

Publications (1)

Publication Number Publication Date
SK23898A3 true SK23898A3 (en) 1999-05-07

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
SK238-98A SK23898A3 (en) 1995-08-29 1996-07-29 Zwitterionic forms of trovafloxacin

Country Status (30)

Country Link
EP (1) EP0850060A1 (xx)
JP (1) JP3188476B2 (xx)
KR (1) KR100343909B1 (xx)
CN (1) CN1190889A (xx)
AP (1) AP636A (xx)
AR (1) AR003985A1 (xx)
AU (1) AU704115B2 (xx)
BR (1) BR9609998A (xx)
CA (1) CA2229786C (xx)
CO (1) CO4480739A1 (xx)
CZ (1) CZ56698A3 (xx)
DZ (1) DZ2087A1 (xx)
GT (1) GT199600072A (xx)
HR (1) HRP960395B1 (xx)
HU (1) HUP9900170A3 (xx)
IL (1) IL122651A (xx)
MA (1) MA23966A1 (xx)
MY (1) MY113874A (xx)
NO (1) NO309814B1 (xx)
NZ (1) NZ312199A (xx)
OA (1) OA10669A (xx)
PE (1) PE12598A1 (xx)
PL (1) PL325170A1 (xx)
RU (1) RU2144921C1 (xx)
SK (1) SK23898A3 (xx)
TN (1) TNSN96109A1 (xx)
TR (1) TR199800339T1 (xx)
WO (1) WO1997007800A1 (xx)
YU (1) YU48396A (xx)
ZA (1) ZA967282B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
ZA967282B (en) 1998-03-02
JPH10511692A (ja) 1998-11-10
KR19990044232A (ko) 1999-06-25
MY113874A (en) 2002-06-29
EP0850060A1 (en) 1998-07-01
AU6367696A (en) 1997-03-19
IL122651A0 (en) 1998-08-16
JP3188476B2 (ja) 2001-07-16
CA2229786A1 (en) 1997-03-06
AR003985A1 (es) 1998-09-30
HUP9900170A3 (en) 1999-11-29
AP636A (en) 1998-04-09
AP9600853A0 (en) 1996-10-31
CO4480739A1 (es) 1997-07-09
NO980862D0 (no) 1998-02-27
MX9801664A (es) 1998-08-30
IL122651A (en) 2000-02-17
WO1997007800A1 (en) 1997-03-06
NO309814B1 (no) 2001-04-02
YU48396A (sh) 1998-12-23
BR9609998A (pt) 1999-07-06
TR199800339T1 (xx) 1998-06-22
OA10669A (en) 2000-11-06
PL325170A1 (en) 1998-07-06
NO980862L (no) 1998-02-27
TNSN96109A1 (fr) 2005-03-15
GT199600072A (es) 1998-02-14
PE12598A1 (es) 1998-03-20
KR100343909B1 (ko) 2003-04-10
MA23966A1 (fr) 1997-04-01
DZ2087A1 (fr) 2002-07-22
HUP9900170A2 (hu) 1999-05-28
HRP960395A2 (en) 1998-06-30
RU2144921C1 (ru) 2000-01-27
AU704115B2 (en) 1999-04-15
CA2229786C (en) 2002-02-19
HRP960395B1 (en) 2001-12-31
CN1190889A (zh) 1998-08-19
NZ312199A (en) 1999-06-29
CZ56698A3 (cs) 1999-02-17

Similar Documents

Publication Publication Date Title
HRP20010281A2 (en) New crystalline form of omeprazole
PL190869B1 (pl) Sól sodowa omeprazolu, sposób jej wytwarzania, środek farmaceutyczny i zastosowanie soli sodowej omeprazolu
US5763454A (en) Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
SK10372001A3 (sk) Draselná soľ (S)-omeprazolu
EP0579681B1 (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
SK23898A3 (en) Zwitterionic forms of trovafloxacin
JPH06504541A (ja) ４−アミノ−３−アシルキノリン誘導体の塩およびその胃酸分泌抑制剤としての使用
US6066647A (en) Zwitterionic forms of trovafloxacin
SK281980B6 (sk) Kryštallický (+)l-hydrogenvínan, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie
EP0847400B1 (en) Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
EP0584588A1 (en) Anti-ulcer composition containing imidazole derivative
EP1314726A1 (en) Novel ester or amide derivatives
MXPA98001664A (en) Zwitterionic forms of trovafloxacin, procedure for its preparation, compositions that contain them and use of the mis
AP788A (en) Novel crystal form of anhydrous 7-(1a, 5a, 6a)-6-Amino-3-Azabicyclo(3.1.0) hex-3-YI)-6-Fluoro-1-(2,4- Difluorophenyl)-1,4-Dihydro-4-Oxo-1, 8-Naphthyridine-3-Carboxylic Acid, Methanesulfonic acid salt.
KR20200068667A (ko) 고체 형태의 스테모스피로닌 및 이의 염
SI21064A2 (sl) Amidni derivat amlodipina